10x Genomics, Inc. — Director's Dealing 2020

Sep 3, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: 10x Genomics, Inc. (TXG)
CIK: 0001770787
Period of Report: 2020-09-01

Reporting Person: CRUTCHFIELD BRADFORD (Chief Commercial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-09-01	Class A Common Stock	M	13776	$1.16	Acquired	14739	Direct
2020-09-01	Class A Common Stock	S	2600	$112.9204	Disposed	12139	Direct
2020-09-01	Class A Common Stock	S	5887	$113.8214	Disposed	6252	Direct
2020-09-01	Class A Common Stock	S	4789	$114.6459	Disposed	1463	Direct
2020-09-01	Class A Common Stock	S	500	$115.4088	Disposed	963	Direct
2020-09-02	Class A Common Stock	M	3224	$1.16	Acquired	4187	Direct
2020-09-02	Class A Common Stock	S	1000	$111.3273	Disposed	3187	Direct
2020-09-02	Class A Common Stock	S	1496	$112.3226	Disposed	1691	Direct
2020-09-02	Class A Common Stock	S	528	$113.1799	Disposed	1163	Direct
2020-09-02	Class A Common Stock	S	150	$114.10	Disposed	1013	Direct
2020-09-02	Class A Common Stock	S	50	$114.89	Disposed	963	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-09-01	Stock Option (right to buy)	$1.16	M	13776	Disposed	2027-02-03	Class A Common Stock (13776)	Direct
2020-09-02	Stock Option (right to buy)	$1.16	M	3224	Disposed	2027-02-03	Class A Common Stock (3224)	Direct

Footnotes

F1: The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person.

F2: This transaction was executed in multiple trades at prices ranging from $112.25 to $113.23. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F3: This transaction was executed in multiple trades at prices ranging from $113.26 to $114.18. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F4: This transaction was executed in multiple trades at prices ranging from $114.27 to $115.25. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F5: This transaction was executed in multiple trades at prices ranging from $115.29 to $115.50. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F6: This transaction was executed in multiple trades at prices ranging from $110.79 to $111.72. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F7: This transaction was executed in multiple trades at prices ranging from $111.80 to $112.74. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F8: This transaction was executed in multiple trades at prices ranging from $112.82 to $113.655. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F9: This transaction was executed in multiple trades at prices ranging from $113.82 to $114.57. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

F10: This option, originally for 800,000 shares, of which 115,776 shares have been exercised, vested as to one-fourth of the shares on February 2, 2018 and one forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.

F11: This option, originally for 800,000 shares, of which 119,000 shares have been exercised, vested as to one-fourth of the shares on February 2, 2018 and one forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.